The relative burden of haemophilia A and the impact of target joint development on health-related quality of life: results from the ADVATE Post-Authorization Safety Surveillance (P... von KLAMROTH, R., POLLMANN, H., HERMANS, C., FARADJI, A., YARLAS, A. S., EPSTEIN, J. D, EWENSTEIN, B. M

Volltext

Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens von COLLINS, P. W., BJÖRKMAN, S., FISCHER, K., BLANCHETTE, V., OH, M., SCHROTH, P., FRITSCH, S., CASEY, K., SPOTTS, G., EWENSTEIN, B. M.

Volltext

Comparative pharmacokinetics of plasma‐ and albumin‐free recombinant factor VIII in children and adults: the influence of blood sampling schedule on observed age‐related difference... von BJÖRKMAN, S., BLANCHETTE, V. S., FISCHER, K., OH, M., SPOTTS, G., SCHROTH, P., FRITSCH, S., PATRONE, L., EWENSTEIN, B. M., COLLINS, P. W.

Volltext

Association of peak factor VIII levels and area under the curve with bleeding in patients with haemophilia A on every third day pharmacokinetic-guided prophylaxis von Valentino, L. A., Pipe, S. W., Collins, P. W., Blanchette, V. S., Berntorp, E., Fischer, K., Ewenstein, B. M., Oh, M., Spotts, G.

Volltext

Plasma and albumin‐free recombinant factor VIII: pharmacokinetics, efficacy and safety in previously treated pediatric patients von BLANCHETTE, V. S., SHAPIRO, A. D., LIESNER, R. J., HERNÁNDEZ NAVARRO, F., WARRIER, I., SCHROTH, P. C., SPOTTS, G., EWENSTEIN, B. M.

Volltext

Clinical evaluation of an advanced category antihaemophilic factor prepared using a plasma/albumin-free method: pharmacokinetics, efficacy, and safety in previously treated patient... von Tarantino, M. D., Collins, P. W., Hay, C. R. M., Shapiro, A.D., Gruppo, R. A., Berntorp, E., Bray, G. L., Tonetta, S. A., Schroth, P. C., Retzios, A. D., Rogy, S. S., Sensel, M. G., Ewenstein, B. M.

Volltext

Successful treatment for patients with von Willebrand disease undergoing urgent surgery using factor VIII/VWF concentrate (Humate-P®) von Thompson, A. R., Gill, J. C., Ewenstein, B. M., Mueller-Velten, G., Schwartz, B. A.

Volltext

Consensus recommendations for use of central venous access devices in haemophilia von Ewenstein, B. M., Valentino, L. A., Journeycake, J. M., Tarantino, M. D., Shapiro, A. D., Blanchette, V. S., Hoots, W. K., Buchanan, G. R., Manco-Johnson, M. J., Rivard, G.-E., Miller, K. L., Geraghty, S., Maahs, J. A., Stuart, R., Dunham, T., Navickis, R. J.

Volltext

A multiparameter analysis of sickle erythrocytes in patients undergoing hydroxyurea therapy von BRIDGES, K. R, BARABINO, G. D, MULKERN, R. V, ZHANG, B, EATON, W. A, BRUGNARA, C, CHO, M. R, CHRISTOPH, G. W, DOVER, G, EWENSTEIN, B. M, GOLAN, D. E, GUTTMANN, C. R. G, HOFRICHTER, J

Volltext

Immune tolerance induction in hemophilia patients with inhibitors: costly can be cheaper von Colowick, Alan B., Bohn, Rhonda L., Avorn, Jerry, Ewenstein, Bruce M.

Volltext

Regulated Secretion in Endothelial Cells: Biology and Clinical Implications von Datta, Yvonne H., Ewenstein, Bruce M.

Volltext

Successful treatment of urgent bleeding in von Willebrand disease with factor VIII/VWF concentrate (Humate-P®): use of the ristocetin cofactor assay (VWF:RCo) to measure potency an... von Gill, J. Cox, Ewenstein, B. M., Thompson, A. R., Mueller-Velten, G., Schwartz, B. A.

Volltext

Pulmonary embolism and deep venous thrombosis during pregnancy or oral contraceptive use: Prevalence of factor V Leiden von Hirsch, Denise R., Mikkola, Katriina M., Marks, Peter W., Fox, Edward A., Dorfman, David M., Ewenstein, Bruce M., Goldhaber, Samuel Z.

Volltext

Nephrotic syndrome as a complication of immune tolerance in hemophilia B von Ewenstein, B M, Takemoto, C, Warrier, I, Lusher, J, Saidi, P, Eisele, J, Ettinger, L J, DiMichele, D

Volltext

Continuous Infusion of Recombinant Factor VIIa: Continue or not? von Ewenstein, Bruce M.

Volltext

Inhibitor development in patients receiving recombinant factor VIII (Recombinate rAHF/Bioclate®): a prospective pharmacovigilance study von Ewenstein, B. M., Gomperts, E. D., Pearson, S., O'Banion, M. E.

Volltext

Factor IX inhibitors and anaphylaxis in hemophilia B von WARRIER, I, EWENSTEIN, B. M, KATZ, J, BERGMANN, F, LJUNG, R, PETRINI, P, LUSHER, J. M, KOERPER, M. A, SHAPIRO, A, KEY, N, DIMICHELE, D, MILLER, R. T, PASI, J, RIVARD, G. E, SOMMER, S. S

Volltext

A cost minimization model for the treatment of minor bleeding episodes in patients with haemophilia A and high-titre inhibitors von Putnam, K. G., Bohn, R. L., Ewenstein, B. M., Winkelmayer, W. C., Avorn, J.

Volltext

Peptido-leukotrienes are potent agonists of von Willebrand factor secretion and P-selectin surface expression in human umbilical vein endothelial cells von DATTA, Y. H, ROMANO, M, JACOBSON, B. C, GOLAN, D. E, SERHAN, C. N, EWENSTEIN, B. M

Volltext

Re: low incidence of factor VIII inhibitors in PUPs during prophylaxis, on-demand treatment and surgical procedures, with Octanate®: interim report from an ongoing prospective clin... von EWENSTEIN, B. M., REININGER, A. J.

Volltext